Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewIntravenous ascorbic acid to prevent and treat cancer-associated sepsis?Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker.Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients.Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancerClinical significance of preoperative inflammatory parameters in gastric cancer patients.Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer.Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population.Monitoring of peri-distal gastrectomy carbohydrate antigen 19-9 level in gastric juice and its significance.Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells.Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC).C-reactive protein reference percentiles among pre-adolescent children in Europe based on the IDEFICS study population.Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel.Elevated levels of serum fatty acid synthase in patients with gastric carcinoma.Interleukins 17 and 23 in patients with gastric neoplasms.Interleukin 6 gene polymorphism -174 is associated with the diffuse type gastric carcinoma.
P2860
Q26741263-766F091B-9C56-428C-BDE3-5E0367BA7052Q26771557-6CE9CF91-09A0-40C2-B306-3D3501425C66Q34704572-96B5C13D-1D30-4CC8-B43E-BD00B3C1E9DFQ35713297-15B8A789-31F0-4FC8-A984-5CF6F0FE326BQ36447087-CBDD83BA-9B8A-4500-A92E-546C23132DE0Q36803441-36FE50E5-10EC-4102-8052-439AAA2C72D8Q36993466-B0C1CCA1-91B6-4D45-B3F5-72826A5C1BC9Q37289444-5B6EC302-0441-441D-A841-EB1C97B2A95CQ37317497-18DE0D1D-3458-4969-BFA8-8E6C36125583Q37516412-901B38E1-92CB-4CD6-935E-D4A4A43626D5Q38784349-C3DAA5A5-DB8A-4162-9673-F6C55179CC12Q38896287-05257554-E13F-4740-8CF3-61CEC9C88A27Q39102181-32F1C901-3A03-42BC-B361-E17391F6C6ABQ39250942-67BDDBD8-5F5E-4A6D-9A8E-F8115508BD9AQ41942607-B6B022E4-8C41-4367-A846-218609E1BB4BQ42243655-976DCA00-CC79-47FB-82AF-4999C9CEA51BQ47915868-CCBA4211-B874-4ADC-8EA8-1070BFE703BE
P2860
Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@ast
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@en
Comparison between clinical significance of serum proinflammatory proteins
@nl
type
label
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@ast
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@en
Comparison between clinical significance of serum proinflammatory proteins
@nl
prefLabel
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@ast
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@en
Comparison between clinical significance of serum proinflammatory proteins
@nl
P2093
P2860
P1476
Comparison between clinical si ...... nd CA 19-9) in gastric cancer.
@en
P2093
Bogusław Kędra
Maciej Szmitkowski
Mariusz Gryko
Marta Lukaszewicz-Zając
P2860
P2888
P356
10.1007/S10238-010-0114-5
P577
2010-10-12T00:00:00Z
P5875
P6179
1030044009